ArticleChemistry, an Asian journal2025
Synthesis of BODIPY-Linked N-Heterocyclic Carbene Metal Complexes for Cancer Chemotheranostics and Catalysis Applications.
Article in Chemistry, an Asian journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synthesis of BODIPY-Linked N-Heterocyclic Carbene Metal Complexes for Cancer Chemotheranostics and Catalysis Applications.Chemistry, an Asian journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Fluorescent N-heterocyclic carbene (NHC) metal complexes are useful for various chemical and biological applications. In this study, we developed a simple strategy to synthesize BODIPY-linked NHC metal complexes involving Ag, Cu, Ni, and Pd. The synthesis began with the preparation of BODIPY-imidazolium salt as a precursor ligand. This ligand was used to obtain BODIPY-imidazolium silver carbene complex, which subsequently facilitated the syntheses of BODIPY-linked NHC transition metal complexes (Cu, Ni, and Pd) via the transmetalation method. This approach offers a versatile pathway for the synthesis of various other fluorescent carbene metal complexes. The applications of these BODIPY-linked NHC metal complexes were also explored. Chemotherapeutic anti-cancer activity of BODIPY-imidazolium silver carbene complex showed high cancer cell killing efficacy as compared to its precursor ligand. This outcome confirmed that the attachment of the silver atom is essential to enhance the cytotoxic activities. Additionally, the fluorescence property of the BODIPY moiety is highly useful for cellular imaging, which establishes the silver complex as a potential chemotheranostic agent for cancer management. Furthermore, BODIPY-imidazolium copper carbene complex was explored as a non-noble metal-based catalyst for ammonia borane (AB) hydrolysis to generate hydrogen. This catalytic system was further applied for chemoselective reduction of the aromatic formyl groups in the presence of other reducible functional groups. Overall, this investigation presents a simple and efficient design strategy for the synthesis of different BODIPY-linked metal carbene complexes with potential applications in catalysis, cellular imaging, and cancer therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.